MedPath

Dry Eye Test

Dry Eye Test

Approved
Approval ID

04866053-f973-471e-b3bc-241fb76303a2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 23, 2019

Manufacturers
FDA

Nomax Inc.

DUNS: 103220273

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fluorescein Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51801-008
Product Classification
G
Generic Name
Fluorescein Sodium
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateDecember 23, 2019
FDA Product Classification

INGREDIENTS (1)

Fluorescein SodiumActive
Quantity: 0.12 mg in 1 1
Code: 93X55PE38X
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dry Eye Test - FDA Drug Approval Details